Bengmark, 2005 - Google Patents
Bioecologic control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbioticsBengmark, 2005
View PDF- Document ID
- 8815819239390591272
- Author
- Bengmark S
- Publication year
- Publication venue
- Gastroenterology Clinics
External Links
Snippet
EPIDEMIC OF CHRONIC DISEASES Although in certain parts of the world acute infectious diseases still dominate as causes of death, especially in children, globally chronic diseases constitute the leading causes of morbidity and mortality today. The World Health …
- 235000018291 probiotics 0 title description 69
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bengmark | Bioecologic control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics | |
| Vieira et al. | The role of probiotics and prebiotics in inducing gut immunity | |
| Markowiak et al. | Effects of probiotics, prebiotics, and synbiotics on human health | |
| Saez-Lara et al. | The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials | |
| Pandey et al. | Probiotics, prebiotics and synbiotics-a review | |
| Huang et al. | Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022 | |
| Patel et al. | New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics | |
| Rupa et al. | Recent advances in the role of probiotics in human inflammation and gut health | |
| Pham et al. | Probiotics: sorting the evidence from the myths | |
| Andermann et al. | Microbiota manipulation with prebiotics and probiotics in patients undergoing stem cell transplantation | |
| Hajela et al. | Gut microbiome, gut function, and probiotics: Implications for health | |
| Del Piano et al. | Evaluation of the intestinal colonization by microencapsulated probiotic bacteria in comparison with the same uncoated strains | |
| CN103491969A (en) | Synbiotic compositions for restoration and reconstitution of gut microbiota | |
| Basson et al. | Complementary and alternative medicine strategies for therapeutic gut microbiota modulation in inflammatory bowel disease and their next-generation approaches | |
| Lou et al. | Postbiotics as potential new therapeutic agents for sepsis | |
| Kango et al. | Prebiotics, probiotics and postbiotics: the changing paradigm of functional foods | |
| Fabbiano et al. | Host–microbiota mutualism in metabolic diseases | |
| Khorashadizadeh et al. | The Role of Microbiome and Probiotics in Chemo‐Radiotherapy‐Induced Diarrhea: A Narrative Review of the Current Evidence | |
| Yang et al. | Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection | |
| Hickson | Examining the evidence for the use of probiotics in clinical practice | |
| Parkes | An overview of probiotics and prebiotics | |
| Arora et al. | Therapeutic potential of probiotics: A ray of hope or nightmare? | |
| Quigley | Probiotics in the management of colonic disorders | |
| Kvasnovsky et al. | What colorectal surgeons should know about probiotics: a review. | |
| Sankarganesh et al. | Prebiotics and probiotics food: future aspects |